Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer

Cancer Research

Volumn 41, Issue , 1981, Pages 3360-3363

  Zumoff, Barnett ^a   Levin, Joseph ^a   Strain, Gladys W ^a   Markham, Mark ^a   Rosenfeld, Robert S ^a   Fukushima, David K ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; PRASTERONE SULFATE;

BLOOD AND HEMOPOIETIC SYSTEM; BREAST; BREAST CARCINOMA; CASE REPORT; DIAGNOSIS; PLASMA;

ADULT; AGE FACTORS; AGED; ANDROSTERONE; BREAST NEOPLASMS; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0019513506     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Allen, B. J., Hayward, J. L., and Merivale, W. H. H., The excretion of 17-ketosteroids in the urine of patients with generalized carcinomatosis secondary to carcinoma of the breast. Lancet, 1: 496–499, 1967.
2. Boyar, R. M., Finkelstein, J. W., David, R., Roffwarg, H., Kapen, S., Weitz-Man, E. D., and Heilman, L., Twenty-four hour patterns of plasma luteinizing hormone and follicle-stimulating hormone in sexual precocity. N. Engl. J. Med., 289. 282–286, 1973.
3. Boyar, R. M., Kapen, S., Finkelstein, J. W., Perlow, M., Sassin, J. F., Fukushima, D. K., Weitzman, E. D., and Hellman, L., Hypothalamic-pituitary function in diverse hyperprolactinemic states. J. Clin. Invest., 53: 1588–1598, 1974.
4. Boyar, R. M., Rosenfeld, R. S., Kapen, S., Finkelstein, J. W., Roffwarg, H. P., Weitzman, E. D. and Heilman, L., Human puberty: simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. J. Clin. Invest., 54: 609–618, 1974.
5. Brownsey, B., Cameron, E. H. D., Griffiths, K., Gleave, E. N., Forrest, A. P. M., and Campbell, H., Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast disease. Eur. J. Cancer, 8: 131—137, 1972.
6. Bulbrook, R. D., Hayward, J. L., and Spicer, C. C., Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet, 2: 395–398, 1971.
7. Bulbrook, R. D., Hayward, J. L., Spicer, C. C., and Thomas, B. S., Abnormal excretion of urinary steroids by women with early breast cancer. Lancet, 2: 1238–1240, 1962.
8. DeWaard, F., DeLaive, J. W. J., and Baanders-Van Halewijn, E. A., On the bimodal age distribution of mammary carcinoma. Br. J. Cancer,14: 437–448, 1960.
9. Hellman, L., Nakada, F., Curti, J., Weitzman, E. D., Kream, J., Roffwarg, H. P., Ellman, S., Fukushima, D. K., and Gallagher, T. F., Cortisol is secreted episodically by normal man. J. Clin. Endocrinol. Metab., 30: 411–422, 1970.
10. Juret, P., Hayem, M., and Flaisler, A., À propos de 150 implantations d'yttrium radio-actif intra-hypophysaires dans le traitement du cancer du sein à un stade avancé technique; bilan clinique; indications. J. Chir., 87: 409–433, 1964.
11. Kream, J., Hellman, L., and Rosenfeld, R. S., Radioimmunoassay of androsterone and androsterone-3-sulfate in plasma. Steroids, 27. 727–739,1976.
12. Krieger, D. T., and Glick, S., Absent sleep peak of growth hormone release in blind subjects: correlation with sleep EEG stages. J. Clin. Endocrinol. Metab., 33; 847–850, 1971.
13. Kumaoka, S., Sakauchi, N., Abe, O., Kusama, M., and Takatani, O., Urinary 17-ketosteroid excretion of women with advanced breast cancer. J. Clin. Endocrinol. Metab., 28: 667–672, 1968.
14. Lenton, E. A., Cooke, I. D., Sampson, G. A., and Sexton, L., Oestradiol secretion in men and premenopausal women. Clin. Endocrinol., 9: 37–47, 1978.
15. Manton, K. G., and Stallard, E., A two-disease model of female breast cancer: mortality in 1969 among white females in the United States. J. Natl. Cancer Inst., 64: 9–16, 1980.
16. Nieschlag, E., Loriaux, D. L., and Lipsett, M. B., Radioligand assay for Δ5–3β-hydroxysteroids. I. 3β-hydroxy-5-androsten-17-one and its 3-sulfate. Steroids. 19: 669–676, 1972.
17. Parker, D. C., Judd, H. L., Rossman, L. G., and Yen, S. S. C., Pubertal sleep-wake patterns of episodic LH, FSH, and testosterone release in twin boys. J. Clin. Endocrinol. Metab., 40: 1099–1109, 1975.
18. Rose, D. P., Stauber, P., Thiel, A. Crowley, J. J., and Milbrath, J. R., Plasma dehydroepiandrosterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer. Eur. J. Cancer, 13: 43–47, 1977.
19. Rosenfeld, R. S., Heilman, L., Roffwarg, H., Weitzman, E. D., Fukushima, D. K., and Gallagher, T. F., Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. J. Clin. Endocrinol. Metab., 33. 87–92, 1971.
20. Rosenfeld, R. S., Rosenberg, B. J., Fukushima, D. K., and Hellman, L., 24-hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J. Clin. Endocrinol. Metab., 40: 850–855, 1975.
21. Schwartz, A. G., Inhibition of spontaneous breast cancer formation in female C3H AVY/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res., 39: 1129–1132, 1979.
22. Šonkâ, J., Vitkovâ, M., Gregorovâ, I., Tomsovâ, Z., Hilgertova, J., and Staś, J., Plasma and urinary dehydroepiandrosterone in cancer. Endokrinologie, 62: 61–68, 1973.
23. Takahashi, Y., Kipnis, D. M., and Daughaday, W. H., Growth hormone secretion during sleep. J. Clin. Invest., 47: 2079–2090, 1968.
24. Thomas, B. S., Kirby, P., Symes, E. K., and Wang, D. Y., Plasma dehydroepiandrosterone concentration in normal women and in patients with benign and malignant breast disease. Eur. J. Cancer, 12: 405–409, 1976.
25. Wang, D. Y., Plasma androgens in breast cancer In: K. Griffiths and E. H. D. Cameron (eds.). Human Adrenal Gland and Its Relation to Breast Cancer. First Tenovus Workshop, pp. 71–79. Cardiff, Wales: Alpha Omega Alpha, 1971.
26. Wang, D. Y., Bulbrook, R. D., and Hayward, J. L., Urinary and plasma androgens and their relation to familial risk of breast cancer. Eur J. Cancer, 11: 873–877, 1975.
27. Wang, D. Y., Bulbrook, R. D., and Hayward, J. L., Plasma androstenedione levels in women with breast cancer. Eur. J. Cancer, 13: 187–192, 1977.
28. Wang, D. Y., Bulbrook, R. D., Herian, M., and Hayward, J. L., Studies on the sulphate esters of dehydroepiandrosterone and androsterone in the blood of women with breast cancer. Eur. J. Cancer, 10: 477–482, 1974.
29. Weitzman, E. D., Schaumberg, H., and Fishbein, W., Plasma 17-hydroxycor-ticosteroid levels during sleep in man. J. Clin. Endocrinol. Metab., 26: 121–127, 1966.
30. West, C. D., Mahajan, D. K., Chavre, V. J., Nabors, C. J., and Tyler, F. H., Simultaneous measurement of multiple plasma steroids by radioimmunoassay demonstrating episodic secretion. J. Clin. Endocrinol. Metab., 36: 1230–1236, 1973.
31. Yen, S. S. C., Tsai, C. C., Naftolin, F., Vandenberg, G., and Ajabor, L., Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J. Clin. Endocrinol. Metab., 34: 671–675, 1972.
32. Zumoff, B., Rosenfeld, R. S., Strain, G. W., Levin, J., and Fukushima, D. K., Sex difference in the 24-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J. Clin. Endocrinol. Metab., 51: 330–333, 1980.